why semaglutide stops working GLP-1 Plateau Effect: Scientists discover why Ozempic and

Emerging role of GLP-1 agonists in obesity: A Comprehensive review of randomised controlled trials

Here are the average weight loss results based on the dose and timeline: 1 mg: 7.2% in 24 weeks and 8.7% in 48 weeks 4 mg: 12.9% in 24 weeks and 16.3% in 48 weeks 8 mg: 17.3% in 24 weeks and 23.9% in 48 weeks 12 mg: 17.5% in 24 weeks and 24.2% in 48 weeks Placebo: 1.6% in 24 weeks and 2.1% in 48 weeks The retatrutide clinical trials are still ongoing, with a phase IV planned after the current phase III

The available doses of semaglutide tablets are 3 mg, 7 mg, and 14 mg

Your healthcare provider can help determine if adjustments are needed

18-Month Treatment Comparison For an 18-month treatment course (common for achieving significant weight loss): Ozempic without assistance: $17,442 Compounded semaglutide: $3,582 Difference: $13,860 This substantial difference explains why many people choose compounded alternatives even when they could potentially access brand-name options through insurance with prior authorization battles and uncertainty about ongoing coverage